Stoelzle Will Present Enhanced EcoSecur at CPhI 2026
The glass manufacturer plans to showcase its upgraded pharmaceutical packaging technology at the upcoming event.
Updated on Sept. 22, 2026 in Consumer Goods
Live Poll
Will manufacturing innovations aimed at reducing waste lead to more reliable pharmaceutical products for patients?
Stoelzle Glass Group will exhibit its enhanced EcoSecur pharmaceutical glass packaging at CPhI Worldwide 2026 in Milan. The presentation will take place from October 6 to 8, 2026.
Why it matters
The company utilizes a specialized liquid-injection method to improve hydrolytic resistance and coating consistency for medical therapies. This approach aims to enhance production safety and reduce material waste during the manufacturing process.
Stoelzle produces the EcoSecur range in flint and amber glass using Type 3 soda-lime material. The available bottle formats span from 7 ml to 500 ml.
The players
Stoelzle Glass Group
This international manufacturer specializes in the production of high-quality glass packaging for the pharmaceutical and spirits industries.
The details
Manufactured at a facility in Köflach, Austria, the product features an inner-surface treatment applied through a precise liquid-injection process. The design adheres to strict European and US pharmacopoeia requirements to ensure compatibility with injectable and infusion therapies.
Timeline
EcoSecur has been commercially available since 2021.
CPhI Worldwide 2026 will take place from October 6 to 8, 2026.
Market Landscape
This move reflects a broader trend toward specialized glass treatments that meet increasingly stringent global pharmacopoeia standards. By optimizing production consistency, the company strengthens its position in the competitive pharmaceutical supply chain.
Pharmaceutical manufacturers can anticipate improved hydrolytic resistance and material efficiency when integrating these glass solutions into their supply chains. The standardization of these bottles across varied sizes helps streamline compliance and safety protocols for medical providers.
The takeaway
Advancements in liquid-injection manufacturing allow for more precise control over the physical properties of pharmaceutical packaging. Companies should evaluate these technical upgrades when seeking to enhance product safety and consistency for injectable therapy lines.
Further reading
For more on industry developments, visit the Consumer Goods section.
Source note: This article includes information reported by Manufacturingchemist.
Live Poll
Will manufacturing innovations aimed at reducing waste lead to more reliable pharmaceutical products for patients?
